Icahn carries on with Reckson bid
689474
Billionaire Carl Icahn charged ahead on Monday in his efforts to acquire Reckson Associates Realty Corp.  and an affiliate company for $49 per share, or $4.3 billion in cash and stock, even as his former partners in the deal pulled out of the running.
405872
New York real estate magnate Harry  Macklowe backed away from a bid for Reckson Associates Realty  Corp. , leaving former partner Carl Icahn alone to pursue  an offer for the commercial real estate firm, a source familiar  with the situation said on Sunday.
664157
Financier Carl Icahn on Friday offered to buy the shares of generic drugmaker Mylan Laboratories that he does not already own for $4.9 billion, or $20 a share, according to a government filing.
631019
Reckson Associates Realty Corp.   shareholders approved a near-$4-billion takeover by SL Green  Realty Corp. , but billionaire investor Carl Icahn, who  had made his own Reckson bid, hinted he would not abandon his  fight for some office buildings included the deal.
668745
Board members of the Reckson Associates Realty Corporation voted Monday night to rebuff a second attempt by Carl C. Icahn to buy their company.
162353
Reckson Associates Realty Corp.  has asked potential suitor, a partnership of Carl Icahn and Macklowe Associates, to pick up the pace in making a definitive bid for the New York office building owner.
384241
U.S. investor Carl Icahn sold shares worth $460 million in South Korea's top tobacco company KT&G Corp.  at the bottom of the expected price range on Tuesday, sources familiar with the deal said.
331749
Not buying it. Megafinancier Carl Icahn has made it clear: He&#39;s still opposed to Mylan Laboratories&#39; (nyse: MYL - news - people ) proposed acquisition of King Pharmaceuticals (nyse: KG - news - people ). Despite
110030
Reckson Associates Realty Corp.   shareholders approved a $4 billion takeover by SL Green Realty  Corp. , but billionaire and rival bidder Carl Icahn  hinted he would not abandon his fight for certain Reckson  office buildings.
523584
New York real estate magnate Harry Macklowe backed away from a bid for Reckson Associates Realty Corp. , leaving former partner Carl Icahn alone to pursue an offer for the commercial real estate firm, a source familiar with the situation said on Sunday.
210669
Mylan Laboratories Inc. MYL.N on  Wednesday said investor Carl Icahn's opposition to Mylan's  proposed purchase of King Pharmaceuticals Inc. KG.N does not  affect Mylan's commitment to complete the transaction.
107025
Mylan Laboratories Inc. continued to insist Monday that its $4 billion acquisition of King Pharmaceuticals Inc. was in the company&#39;s best interest, following a meeting last week with Carl Icahn, who opposes the deal.
588024
Financier Carl Icahn on Friday offered to buy the shares of generic drugmaker Mylan Laboratories  that he does not already own for &#36;4.9 billion, or &#36;20 a share, according to a government filing.
321927
Mylan Laboratories&#39; (MYL:NYSE - news - research) board of directors Monday once again rejected investor Carl Icahn&#39;s takeover offer while also questioning his intentions and said it planned to go ahead with its planned acquisition of King Pharmaceuticals
84238
Mylan Laboratories Inc. MYL.N on  Friday said its board of directors remains committed to the  purchase of King Pharmaceuticals Inc. KG.N, despite news that  billionaire investor Carl Icahn won regulatory approval to buy  up to 11.9 percent of Mylan's shares.
189520
Shares of Mylan Laboratories Inc., the largest US maker of generic drugs, surged Thursday after the company said investor Carl Icahn was given the green light by regulators to buy up to $500 million of the company&#39;s stock.
755767
Mylan Laboratories Inc.'s MYL.N board  on Monday rebuffed financier Carl Icahn's bid to buy the  company, and said it remains committed to its $3.37 billion  purchase of brand-name drug-maker King Pharmaceuticals Inc.  KG.N.